Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Farrell

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Pathogens (Basel, Switzerland)|December 2, 2014
Epstein-barr virus sequence variation-biology and diseaseStelios Tzellos, Paul J Farrell
Journal of Cellular Physiology|July 16, 2009
RUNX3-mediated repression of RUNX1 in B cellsGareth Brady, Paul J Farrell
Reviews in Medical Virology|November 17, 2004
Reactivation of Epstein-Barr virus from latencyWolfgang Amon, Paul J Farrell
Journal of Virology|September 20, 2002
Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from LatencyHelen Bryant, Paul J Farrell
Critical Reviews in Eukaryotic Gene Expression|April 6, 2006
RUNX expression and function in human B cellsHannah J Whiteman, Paul J Farrell
Advances in Experimental Medicine and Biology|March 17, 2017
Roles of RUNX in B Cell ImmortalisationMichelle J West, Paul J Farrell
Expert Opinion on Biological Therapy|October 20, 2006
The role of Epstein-Barr virus in cancerSamuel B Pattle, Paul J Farrell
Biomolecules|January 21, 2022
Do Epstein-Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease?Paul J Farrell, Robert E White
Journal of Virology|September 20, 2002
Promoter sequences required for reactivation of Epstein-Barr virus from latencyUlrich K Binné, Wolfgang Amon, Paul J Farrell
Journal of Virology|January 16, 2009
Interaction of Epstein-Barr virus BZLF1 C-terminal tail structure and core zipper is required for DNA replication but not for promoter transactivationCarol M McDonald, Carlo Petosa, Paul J Farrell
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Pathogens (Basel, Switzerland)|December 2, 2014
Epstein-barr virus sequence variation-biology and diseaseStelios Tzellos, Paul J Farrell
Journal of Cellular Physiology|July 16, 2009
RUNX3-mediated repression of RUNX1 in B cellsGareth Brady, Paul J Farrell
Reviews in Medical Virology|November 17, 2004
Reactivation of Epstein-Barr virus from latencyWolfgang Amon, Paul J Farrell
Journal of Virology|September 20, 2002
Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from LatencyHelen Bryant, Paul J Farrell
Critical Reviews in Eukaryotic Gene Expression|April 6, 2006
RUNX expression and function in human B cellsHannah J Whiteman, Paul J Farrell
Advances in Experimental Medicine and Biology|March 17, 2017
Roles of RUNX in B Cell ImmortalisationMichelle J West, Paul J Farrell
Expert Opinion on Biological Therapy|October 20, 2006
The role of Epstein-Barr virus in cancerSamuel B Pattle, Paul J Farrell
Biomolecules|January 21, 2022
Do Epstein-Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease?Paul J Farrell, Robert E White
Journal of Virology|September 20, 2002
Promoter sequences required for reactivation of Epstein-Barr virus from latencyUlrich K Binné, Wolfgang Amon, Paul J Farrell
Journal of Virology|January 16, 2009
Interaction of Epstein-Barr virus BZLF1 C-terminal tail structure and core zipper is required for DNA replication but not for promoter transactivationCarol M McDonald, Carlo Petosa, Paul J Farrell
Pageof 7